Rucaparib in patients with relapsed, primary platinum-sensitive high-grade ovarian carcinoma with germline or somatic BRCA mutations: Integrated summary of efficacy and safety from the phase II study ARIEL2
Konecny, G.E., Oza, A.M., Tinker, A.V., Coleman, R.L., O'Malley, D.M., Maloney, L., Wride, K., Rolfe, L., McNeish, I., Swisher, E.M.Volume:
145
Language:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2017.03.028
Date:
June, 2017
File:
PDF, 125 KB
english, 2017